These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 15082222

  • 21. Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.
    Montine TJ, Markesbery WR, Morrow JD, Roberts LJ.
    Ann Neurol; 1998 Sep; 44(3):410-3. PubMed ID: 9749613
    [Abstract] [Full Text] [Related]

  • 22. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.
    Tanaka M, Kikuchi H, Ishizu T, Minohara M, Osoegawa M, Motomura K, Tateishi T, Ohyagi Y, Kira J.
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315
    [Abstract] [Full Text] [Related]

  • 23. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
    Iłzecka J.
    Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
    [Abstract] [Full Text] [Related]

  • 24. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Jiménez-Jiménez FJ, Hernánz A, Medina-Acebrón S, de Bustos F, Zurdo JM, Alonso H, Puertas I, Barcenilla B, Sayed Y, Cabrera-Valdivia F.
    Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071
    [Abstract] [Full Text] [Related]

  • 25. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Rentzos M, Nikolaou C, Rombos A, Boufidou F, Zoga M, Dimitrakopoulos A, Tsoutsou A, Vassilopoulos D.
    Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
    [Abstract] [Full Text] [Related]

  • 26. Serum and cerebrospinal fluid biochemical markers of ALS.
    Shaw PJ, Williams R.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1 Suppl 2():S61-7. PubMed ID: 11464944
    [Abstract] [Full Text] [Related]

  • 27. Cerebrospinal fluid angiogenin level in patients with amyotrophic lateral sclerosis.
    Iłzecka J.
    Acta Clin Croat; 2008 Jun; 47(2):77-9. PubMed ID: 18949901
    [Abstract] [Full Text] [Related]

  • 28. Quantification of cystatin C in cerebrospinal fluid from various neurological disorders and correlation with G73A polymorphism in CST3.
    Yamamoto-Watanabe Y, Watanabe M, Jackson M, Akimoto H, Sugimoto K, Yasujima M, Wakasaya Y, Matsubara E, Kawarabayashi T, Harigaya Y, Lyndon AR, Shoji M.
    Brain Res; 2010 Nov 18; 1361():140-5. PubMed ID: 20849835
    [Abstract] [Full Text] [Related]

  • 29. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
    Vuletic S, Peskind ER, Marcovina SM, Quinn JF, Cheung MC, Kennedy H, Kaye JA, Jin LW, Albers JJ.
    J Neurosci Res; 2005 May 01; 80(3):406-13. PubMed ID: 15795933
    [Abstract] [Full Text] [Related]

  • 30. The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kaufmann E, Boehm BO, Süssmuth SD, Kientsch-Engel R, Sperfeld A, Ludolph AC, Tumani H.
    Neurosci Lett; 2004 Nov 23; 371(2-3):226-9. PubMed ID: 15519762
    [Abstract] [Full Text] [Related]

  • 31. Identification of potential CSF biomarkers in ALS.
    Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, Cudkowicz ME, Newhall K, Peskind E, Marcus S, Ho L.
    Neurology; 2006 Apr 25; 66(8):1218-22. PubMed ID: 16481598
    [Abstract] [Full Text] [Related]

  • 32. A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein.
    Kuhle J, Regeniter A, Leppert D, Mehling M, Kappos L, Lindberg RL, Petzold A.
    J Neuroimmunol; 2010 Mar 30; 220(1-2):114-9. PubMed ID: 20117845
    [Abstract] [Full Text] [Related]

  • 33. Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor.
    Sen I, Nalini A, Joshi NB, Joshi PG.
    J Neurol Sci; 2005 Aug 15; 235(1-2):45-54. PubMed ID: 15936037
    [Abstract] [Full Text] [Related]

  • 34. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.
    Zoccolella S, Simone IL, Lamberti P, Samarelli V, Tortelli R, Serlenga L, Logroscino G.
    Neurology; 2008 Jan 15; 70(3):222-5. PubMed ID: 18195267
    [Abstract] [Full Text] [Related]

  • 35. Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis.
    Murata T, Ohtsuka C, Terayama Y.
    J Neurol Sci; 2008 Apr 15; 267(1-2):66-9. PubMed ID: 17961597
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses.
    Fiszman ML, Ricart KC, Latini A, Rodríguez G, Sica RE.
    Acta Neurol Scand; 2010 Feb 15; 121(2):120-6. PubMed ID: 19804473
    [Abstract] [Full Text] [Related]

  • 39. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Frutiger K, Lukas TJ, Gorrie G, Ajroud-Driss S, Siddique T.
    Amyotroph Lateral Scler; 2008 Jun 15; 9(3):184-7. PubMed ID: 18574763
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.